載入...
Prospects in Mycobacterium bovis Bacille Calmette et Guérin (BCG) Vaccine Diversity and Delivery: Why does BCG fail to protect against Tuberculosis?
Mycobacterium tuberculosis (M.tb) infection leads to active tuberculosis (TB), a disease that kills one human every 18 seconds. Current therapies available to combat TB include chemotherapy and the preventative vaccine Mycobacterium bovis Bacille Calmette et Guérin (BCG). Increased reporting of drug...
Na minha lista:
| 發表在: | Vaccine |
|---|---|
| Main Authors: | , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
2015
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4577463/ https://ncbi.nlm.nih.gov/pubmed/26319069 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.vaccine.2015.08.033 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|